Kazazian Asset Management’s C4 Therapeutics CCCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-14,250
Closed -$51.3K 63
2024
Q4
$51.3K Buy
+14,250
New +$51.3K 0.04% 52